Regulation of the mRNA half-life in breast cancer

doi:10.5306/wjco.v5.i3.323

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6620)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

387

WORD

209

HTML

4423

Figures (1-1)

143

Tables (1-1)

126

Sum=5288

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

679

Download

653

Sum=1332

Aug 10, 2014 (publication date) through May 20, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Clin Oncol. Aug 10, 2014; 5(3): 323-334
Published online Aug 10, 2014. doi: 10.5306/wjco.v5.i3.323

Open in New Tab Full Size Figure Download Figure

Figure 1 The regulation of the mRNA half-life and targeted therapy in breast cancer. Modulation of mRNA half-life depends on the interaction and balance between RNA binding proteins, regulatory RNAs (miRNA and lncRNA) and alternative polyadenylation in the 3’UTR of genes.

Citation: Griseri P, Pagès G. Regulation of the mRNA half-life in breast cancer. World J Clin Oncol 2014; 5(3): 323-334
URL: https://www.wjgnet.com/2218-4333/full/v5/i3/323.htm
DOI: https://dx.doi.org/10.5306/wjco.v5.i3.323